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Abstract
Background: The proportional distributions of various skin and soft tissue infections (SSTIs) with/without intensive 
care are unclear. Among SSTI patients, the prevalence and significance of complicating factors, such as comorbidities 
and infections other than skin/soft tissue (non-SST infections), remain poorly understood. We conducted this 
population-based study to characterize hospitalized SSTI patients with/without intensive care and to identify factors 
associated with patient outcome.
Methods: We analyzed first-episode SSTIs between January 1, 2005 and December 31, 2007 from the hospitalized 
claims data of a nationally representative sample of 1,000,000 people, about 5% of the population, enrolled in the 
Taiwan National Health Insurance program. We classified 18 groups of SSTIs into three major categories: 1) superficial; 
2) deeper or healthcare-associated; and 3) gangrenous or necrotizing infections. Multivariate logistic regression models 
were applied to identify factors associated with intensive care unit (ICU) admission and hospital mortality.
Results: Of 146,686 patients ever hospitalized during the 3-year study period, we identified 11,390 (7.7%) patients 
having 12,030 SSTIs. Among these SSTI patients, 1,033 (9.1%) had ICU admission and 306 (2.7%) died at hospital 
discharge. The most common categories of SSTIs in ICU and non-ICU patients were "deeper or healthcare-associated" 
(62%) and "superficial" (60%) infections, respectively. Of all SSTI patients, 45.3% had comorbidities and 31.3% had non-
SST infections. In the multivariate analyses adjusting for demographics and hospital levels, the presence of several 
comorbid conditions was associated with ICU admission or hospital mortality, but the results were inconsistent across 
most common SSTIs. In the same analyses, the presence of non-SST infections was consistently associated with 
increased risk of ICU admission (adjusted odds ratios [OR] 3.34, 95% confidence interval [CI] 2.91-3.83) and hospital 
mortality (adjusted OR 5.93, 95% CI 4.57-7.71).
Conclusions: The proportional distributions of various SSTIs differed between ICU and non-ICU patients. Nearly one-
third of hospitalized SSTI patients had non-SST infections, and the presence of which predicted ICU admission and 
hospital mortality.
Background
Skin and soft tissue infections (SSTIs) are common in
outpatient clinic and emergency department visits [1-4]
and include a wide variety of infections of the epidermis,
dermis, subcutaneous tissue, fascia and muscle [3,4].
SSTIs usually result from traumatic, surgical or health-
care-related skin break down with secondary inflamma-
tory microbial invasions [4]. The severity of SSTIs ranges
from mild superficial to deeper or potentially fatal necro-
tizing infections requiring hospitalization or intensive
care [2-8].
Among hospitalized or critically ill patients, several
epidemiological studies have shown that about 4.3%-
10.5% of septic episodes are caused by SSTIs [9-12]. But
data on the proportional distributions of SSTIs with/
without intensive care are still limited [5,8,13-15]. The
available data suggest a marked difference in the propor-
tional distribution between those with/without intensive
care. For example, based on a National Inpatient Sample
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from about 20% of all United States community hospitals,
Edelsberg et al suggested that most hospitalized SSTIs
were either "superficial" (58.6%) or "deeper and/or health-
care-associated" (40.1%) infections; the proportion of
"often fatal" SSTIs was relatively low (1.3%) [5]. In another
large database study on dermatological conditions in the
intensive care unit (ICU) [8], only 0.4% of all ICU admis-
sions had SSTIs, and about 60% of which were necrotiz-
ing fasciitis, a potentially fatal infection. Another two
studies, including only "superficial" and "deep and/or
healthcare-associated" infections, have shown that about
2.0%-5.8% of hospitalized SSTI patients are admitted to
the ICU [14,15]. The proportional distributions of vari-
ous SSTIs with/without intensive care are not reported.
Because SSTIs alone may not result in hospital or ICU
admission, complicating factors such as comorbidities or
associated infections other than skin/soft tissue (non-SST
infections) may be present in hospitalized patients with
SSTIs [8,14,15]. For example, sepsis and pneumonia have
been found to be the most common non-dermatological
reasons for ICU admission in patients with SSTIs [8].
However, the prevalence and significance of these com-
plicating factors in SSTI patients remain poorly under-
stood. Therefore, based on a nationwide population-
based database, we conducted this study to investigate
the characteristics and distributions of hospitalized SSTI
patients with/without intensive care, to compare these
differences across most common SSTIs and to identify
complicating factors, such as comorbidities and non-SST
infections, which might be associated with ICU admis-
sion and hospital mortality.
Methods
Database
A compulsory and universal National Health Insurance
(NHI) program has been initiated by the Taiwan govern-
ment since 1995 [16]. With the exception of prison
inmates, all citizens are enrolled in the program. Patients
in this study were drawn from NHI Research Database
(NHIRD) [16], released for research purposes by the
National Health Research Institute, Taipei, Taiwan. The
NHIRD, which covers nearly all (99%) inpatient and out-
patient claims for its population of >22 million, is one of
the largest and most comprehensive databases in the
world and has been used extensively in various studies
[16-19]. The NHIRD provided encrypted patient identifi-
cation numbers, gender, birthday, dates of admission and
discharge, medical institutions providing the services, the
ICD-9-CM (International Classification of Diseases,
Ninth Revision, Clinical Modification) codes of diagnoses
(up to five) and procedures (up to five), and outcome at
hospital discharge (recovered, died or transferred out).
Study Sample
The study cohort, a randomly selected longitudinal
NHIRD dataset of 1,000,000 people enrolled in 2005 [16],
represented about 5% of the Taiwanese population. There
were no significant differences in age and gender between
the study cohort and the general population [16]. All
health care claims were collected annually for ten years,
which enables us to do longitudinal follow-ups of individ-
ual patients of the cohort during the study period, from
2004 to 2007 (inclusive), to rule out non-first-episode
SSTI hospitalizations. We linked to diagnostic codes
through the hospitalization claims data to identify
patients with a discharge diagnosis of SSTIs and the cor-
responding order codes used for the study subjects. To
ensure the inclusion of first-episode SSTI hospitalization
between 2005 and 2007, patients were excluded if they
had ever been hospitalized for the disease in 2004 or had
subsequent hospitalizations after the first episodes. The
Human Subjects Institutional Review Board Approval
and informed consent were exempt for the use of
encrypted administrative database.
Patient selection and definition
The definitions of SSTIs were based on ICD-9-CM codes,
modified from Edelsberg's classification [5] and included
the following eighteen types: 1) acute lymphadenitis
(ICD-9-CM code 683.x); 2) carbuncle/furuncle (680.x); 3)
cellulitis/abscess of finger/toe (681.x); 4) impetigo
(684.x); 5) amputation stump infection (997.62); 6) other
cellulitis/abscess (682.x); 7) other local SSTIs (686.x); 8)
anal/rectal abscess (566.x); 9) chronic ulcer of specified/
unspecified sites (707.8,707.9); 10) decubitus ulcer
(707.0); 11) infection due to vascular device/implant
(996.62); 12) pilonidal cyst with abscess (685.x); 13) post-
operation wound infection (998.5); 14) post-traumatic
wound infection (958.3); 15) lower limb ulcer except
decubitus (707.1); 16) gangrene (785.4); 17) necrotizing
fasciitis (728.86); and 18) Fournier's gangrene (608.83).
Based on different predominant pathogens and risk of
mortality [5], these SSTIs were further grouped into three
mutually exclusive categories: 1) superficial infections
predominantly caused by Staphylococcus aureus or Strep-
tococcus pyogenes (groups 1-7 above); 2) deeper or
healthcare-associated infections more likely caused by
anaerobic or gram-negative organisms (groups 8-15); and
3) gangrenous or necrotizing infections (or "often fatal
infections") (groups 16-18).
Patients readmitted ≤1 day after discharge from the
same or different hospitals were regarded as the same
hospitalization. We defined a case as having surgical con-
dition if procedure codes, other than tracheostomy, were
present and their surgical charges were more than zero.
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home", "in-hospital death" coded at discharge would
underestimate true hospital mortality. Therefore, we pre-
sumed cases that were attrited from the NHI within 3
days of hospital discharge were in-hospital death because
of the universal insurance coverage and unlikely emigra-
tion of the cases shortly after hospital discharge [18].
Measurements
Demographic and clinical characteristics of study sub-
jects were examined, including age, gender, hospital levels
(medical centers, regional hospitals or district hospitals),
prevalence of selected comorbid conditions, Charlson
comorbidity index [20,21], bacterial or fungal infections
(SSTIs and non-SST infections), and outcome. The
Charlson comorbidity index is a weighted summary mea-
sure of clinically important concomitant diseases that has
been adapted for use with ICD-9-CM coded administra-
tive databases [20,21]. A comprehensive list of ICD-9-CM
codes, which included 1,286 distinct codes for bacterial
and fungal infections defined by Angus et al in an epide-
miological study on severe sepsis [9], was used to identify
non-SST infections.
Statistics
Continuous variables were described as median (inter-
quartile range, IQR); discrete ones as counts or percent-
ages. Univariate and multivariate logistic regression anal-
yses were applied to identify factors associated with ICU
admission and hospital mortality for SSTIs. In case of
small event number, only those with ≥50 ICU cases were
selected for detailed analyses. The Goodness-of-fit of the
logistic regression model was assessed by the Hosmer
and Lemeshow test, and the explanatory power was
reported with a Nagelkerke's pseudo-R-square. Data anal-
ysis was performed using a professional statistical pack-
age, SPSS for Windows, version 17.0. (SPSS Inc., Illinois,
U.S.A.). A two-tailed p value of < 0.05 was considered sig-
nificant.
Results
Demographics and clinical characteristics
Of 146,686 patients ever hospitalized during the 3-year
study period, we identified 11,390 (7.7%) patients having
12,030 SSTIs. Among these SSTI patients, 1,033 (9.1%)
had ICU admission and 306 (2.7%) died at hospital dis-
charge. Demographics and clinical characteristics of all
patients with SSTIs are shown in Table 1. Among non-
SST infections, 76.5% of them were respiratory, intra-
abdominal or genitourinary tract infection (Table 1).
The proportional distributions of SSTIs by groups and
categories are shown in Table 2. The three most common
groups of SSTIs were "other cellulitis or abscess", "decubi-
tus ulcer" and "post-operation wound infection"; and they
accounted for 76.5% of all hospitalized cases and for
72.9% of ICU ones, respectively. In addition, "infection
caused by vascular device/implant", "gangrene" and
"necrotizing fasciitis" comprised another 24.3% of the
ICU cases.
Relative proportions of SSTIs by categories for ICU and
non-ICU cases are shown in Figure 1. The most common
categories of SSTIs in ICU and non-ICU patients were
Table 1: Demographics and clinical characteristics of hospitalized 
skin and soft tissue infections 2005-2007
Variables No %
Variables 11,390 100
Age, yr 58 (39-74)*
<18 872 7.7
18-64 5,824 51.1
≥65 4,694 41.2
Men 6,924 60.8
Women 4,466 39.2
Medical conditions 8,230 72.3
Surgical conditions 3,160 27.7
Hospital level
Medical center 3,293 28.9
Regional hospital 4,786 42.0
District hospital 3,310 29.1
Charlson Comorbidity Index 0 (0-1)*
0 6,235 54.7
1 2,552 22.4
2 1,498 13.2
≥3 1,105 9.7
Comorbid conditions
Chronic obstructive 
pulmonary disease
535 4.7
Congestive heart failure 355 3.1
Cerebrovascular disease 666 5.8
Diabetes mellitus 2,507 22.0
End stage renal disease 567 5.0
Cirrhosis 285 2.5
Cancer 788 6.9
Infections other than skin/soft tis-
sue#
3,570 31.3
Respiratory 1,009 8.9
Intra-abdominal 884 7.8
Genitourinary tract 839 7.4
Others 1,494 13.1
* Values are expressed as median (inter-quartile range).
# Patients may have more than one site of infection other than 
skin and soft tissue.Shen and Lu BMC Infectious Diseases 2010, 10:151
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"deeper or healthcare-associated" and "superficial" infec-
tions, respectively (Figure 1).
Table 3 compares the patient and hospital characteris-
tics and hospital mortality by intensive care status for the
six most common SSTIs in the ICU. Among the six
SSTIs, the ICU admission rates were the highest in
"necrotizing fasciitis" (23.8%, 85/357), followed by "decu-
bitus ulcer" (22.8%), "infection due to vascular device/
implant" (21.2%), "post-operation wound infection"
(17.8%), "gangrene" (15.4%) and "other cellulitis/abscess"
(3.8%), respectively. The median ages of these patients
was the highest in "decubitus ulcer" (78, IQR 69-84 yr)
and the youngest in "other cellulitis or abscess" (54, 35-72
yr) and in "post-operation wound infection" (55, 25-75
yr). Diabetes mellitus was the most common comorbid
condition in most SSTIs except "post-operation wound
infection" and "infection due to vascular device/implant".
The most common comorbid conditions in patients with
"post-operation wound infection" and "infection due to
vascular device/implant" were cancer (18.0%) and end
stage renal disease (ESRD) (51.2%), respectively. Com-
pared with non-ICU patients across the six most com-
mon SSTIs, ICU ones were more likely to have non-SST
infections (44.9%-78.5% vs 17.8%-38.4%).
Factors associated with ICU admission and hospital 
mortality for SSTIs
Factors associated with ICU admission and hospital mor-
tality for the six SSTIs are shown in Table 4 and Table 5,
respectively. After adjusting for demographics and hospi-
tal levels, the presence of several comorbid conditions
was associated with ICU admission or hospital mortality,
but the results were inconsistent across most common
SSTIs. In the same analyses, the presence of non-SST
infections was consistently associated with increased risk
of ICU admission (adjusted odds ratios [OR] 3.34, 95%
confidence interval [CI] 2.91-3.83, for all SSTI patients)
Table 2: Proportional distributions of skin and soft tissue infections by groups and categories 2005-2007 (patient no. = 
10,390)*
Variables n %
Superficial infections 6,840 56.9
Acute lymphadenitis 136 1.1
Carbuncle/funruncle 224 1.9
Cellulitis/abscess of finger/toe 368 3.1
Impetigo 28 0.2
Amputation stump infection 28 0.2
Other cellulitis/abscess 5,982 49.7
Other local soft tissue infection 252 2.1
Deeper or healthcare-associated 
infections
4,317 35.9
Anal/rectal abscess 626 5.2
Chronic ulcer of specified/unspecified 
sites
57 0.5
Decubitus ulcer 1,324 11.0
Infection due to vascular device/
implant
377 3.1
Pilonidal cyst with abscess 17 0.1
Post-operation wound infection 1,262 10.5
Post-traumatic wound infection 212 1.8
Lower limb ulcer except decubitus 498 4.1
Gangrenous or necrotizing Infections 873 7.3
Gangrene 506 4.2
Necrotizing fasciitis 357 3.0
Fournier's gangrene 42 0.3
Total 12,030 100.0
*Patients may have more than one group of skin and soft tissue infection.Shen and Lu BMC Infectious Diseases 2010, 10:151
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and hospital mortality (adjusted OR 5.93, 95% CI 4.57-
7.71).
Discussion
In this study, we found that the proportional distributions
of various SSTIs differed between ICU and non-ICU
patients due to different incidences and ICU admission
rates of these SSTIs. The six most common SSTIs in the
ICU accounted for 97.2% of the ICU cases and included
"decubitus ulcer", "other cellulitis/abscess", "post-opera-
tion wound infection", "necrotizing fasciitis", "infection
due to vascular device/implant" and "gangrene". By analy-
ses of the six SSTIs, SSTIs appeared to vary greatly in
many aspects including demographics, clinical character-
istics and risks of ICU admission and hospital mortality.
Despite these, non-SST infections, present in nearly one-
third of the patients, were consistently associated with
increased risks of ICU admission and hospital mortality.
Compared with Edelsberg's study [5], we found more
"often fatal infections" (7.2% vs 1.3%), less "deeper or
healthcare-associated infections" (35.9% vs 40.1%) and a
similar proportion of "superficial infections" (56.9% vs
58.6%) in the hospitalized patients with SSTIs. However,
compared with another study on dermatological condi-
tions in the ICU [8], the ICU patients with SSTIs in our
study had less "often fatal" (15.0% vs 59.1%) and "superfi-
cial" (23.5% vs 36.8%) infections but much more "deeper
or healthcare-associated infections" (61.6% vs 4.0%). Rea-
sons for the discrepant results may be due to differences
in patient populations, in the ICU triage policies, in the
environmental or geographic characteristics or in the
inclusion criteria of SSTIs [8]. For example, more patients
with non-surgical conditions (72.3% vs 52.8%) and more
types of SSTIs (18 vs 8 types of SSTIs) were included in
Figure 1 Proportions of skin and soft tissue infections (SSTIs) in 
those with/without intensive care unit (ICU) admission. (Note: 
Eighteen types of SSTIs are grouped into three categories according to 
modified Edelsberg's classification [5].)
Table 4: Multivariate analyses for factors associated with intensive care unit admission (Forward logistic regression model)*
Variables Other 
cellulitis or 
abscess
Decubitus 
ulcer
Post-operation 
wound infection
Infection due 
to vascular 
device/implant
Gangrene Necrotizing 
fasciitis
Age ≥65 yr 1.88(1.40-2.52) 2.43(1.75-3.39)
Surgical conditions 5.49(4.04-7.45) 2.46(1.75-3.46) 13.38(7.73-23.17) 2.54(1.40-4.62)
Hospital level
Medical center 11 1
Regional hospital 0.90(0.65-1.24) 1.54(1.06-2.24) 0.38(0.21-0.69)
District hospital 0.56(0.38-0.83) 0.95(0.65-1.40) 0.25(0.10-0.61)
Comorbid conditions
Congestive heart failure 5.01(3.09-8.11) 1.89(1.13-3.19) 4.07(1.03-16.18) 4.07(1.50-11.06) 4.33(1.78-10.56)
Cerebrovascular 
disease
3.25(2.01-5.27) 4.67(2.10-10.36)
End stage renal disease 0.27(0.14-0.53)
Cirrhosis 3.42(2.00-5.85) 35.81(3.77-340.61) 4.28(1.46-12.51)
Cancer 1.95(1.17-3.25) 2.61(1.78-3.82) 0.17(0.08-0.38) 5.35(1.42-20.16)
Infections other than 
SST
4.51(3.40-5.99) 3.27(2.39-4.49) 2.86(2.04-4.02) 2.61(1.52-4.50) 5.01(2.96-8.49) 4.02(2.33-6.95)
P-value for goodness-of-fit 0.081 0.970 0.375 0.846 0.374 0.542
Nagelkerke pseudo-R2 0.202 0.107 0.314 0.200 0.179 0.242
*Values represent adjusted odds ratio (95% confidence interval). Factors used for multivariate analyses included age ≥65 year, gender, medical/
surgical conditions, hospital levels, comorbid conditions and infections other than skin/soft tissue (SST).Shen and Lu BMC Infectious Diseases 2010, 10:151
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our study [8]. Besides, the ICU admission rates for
patients with "superficial" and "deep or healthcare-associ-
ated" infections were higher than other reports (9.0% vs
2.0%-5.8%) [14,15].
The odds of ICU admission were consistently increased
in the presence of non-SST infections across the six most
common SSTIs. Similar findings were observed on the
risks of hospital mortality. This finding is novel but not
surprising because the occurrence of ≥2 sites of infection
usually indicates a severe, secondary or nosocomial infec-
tion and/or a poor host immunity, all of which are associ-
ated with a poor outcome [22].
The presence of significant underlying comorbidities
may complicate or delay response to treatment of SSTIs,
leading to increased risks of treatment failure and mortal-
ity [7,14,23-26]. In this study, we found that the presence
of several comorbid conditions in certain SSTI patients
might increase the risks of ICU admission and hospital
mortality. For example, the presence of congestive heart
failure predicted ICU admission in most SSTI patients
except those with "necrotizing fasciitis". But the effect of
congestive heart failure on mortality was significant only
in those with "post-operation wound infection". On the
other hand, the presence of cancer was the most powerful
and common predictor of hospital mortality in most SSTI
p a t i e n t s  e x c e p t  t h o s e  w i t h  " i n f e c t i o n  d u e  t o  v a s c u l a r
device/implant". These findings are generally in agree-
ment with prior reports [14,23-26].
Among factors associated with ICU admission and hos-
pital mortality, several inconsistent or contradictory
results were observed. For example, (A) in patients with
"decubitus ulcer", the presence of surgical conditions
increased the odds of ICU admission, but reduced the
risk of death. The reason for this contradictory finding is
unclear because the severity of illnesses and the indica-
tions of surgery were not available, rendering further
analyses impossible. Besides, the presence of unmeasured
confounders might also have implications. (B) The pres-
ence of cerebrovascular disease in patients with "other
cellulitis/abscess" or "post-operation wound infection"
increased the odds of ICU admission, whereas its pres-
ence reduced the risk of hospital mortality in those with
"decubitus ulcer". The latter finding is contrary to the
results of one study, which, using national mortality data,
has shown that the presence of cerebrovascular disease in
patients with decubitus ulcer increases the risk of death
(OR 1.4, 95% CI 1.4-1.5) [24]. However, because we only
looked at the short-term outcome and the study methods
are different, the results may not be comparable. And (C)
among patients with "infection due to vascular device/
implant", the presence of cancer or ESRD was associated
with a lower risk of ICU admission, but not related to
hospital mortality. Most of vascular device/implant-
related infections arise either by infection of the local
wound/puncture/exit site or by contamination of the
catheter hub, leading to intraluminal colonization and
Table 5: Multivariate analyses for factors associated with hospital mortality (Forward logistic regression model) *
Variables Other cellulitis 
or abscess
Decubitus 
ulcer
Post-
operation 
wound 
infection
Infection due to 
vascular device/
implant
Gangrene Necrotizing 
fasciitis
Age ≥65 yr 2.83(1.66-4.83) 4.02(1.62-9.96) 4.35(1.27-14.87)
Surgical conditions 2.14(1.16-3.94) 0.46(0.24-0.84)
Comorbid conditions
Congestive heart 
failure
9.66(1.72-54.20)
Cerebrovascular 
disease
0.45(0.24-0.84)
End stage renal disease 3.05(1.28-7.26)
Cirrhosis 2.55(1.06-6.12) 7.84(1.17-52.31) 8.75(2.56-29.80)
Cancer 10.44(5.83-18.68) 3.99(2.35-6.75) 5.65(2.39-13.35) 4.39(1.04-18.40) 24.74(6.09-100.39)
Infections other than 
SST
8.43(4.95-14.36) 1.56(1.02-2.38) 9.04(3.61-22.62) 11.04(3.16-38.50) 4.27(1.96-9.29) 7.28(2.80-18.92)
P-value for goodness-of-fit 0.265 0.854 0.045 0.452 0.358 0.667
Nagelkerke pseudo-R2 0.229 0.072 0.242 0.172 0.156 0.319
*Values represent adjusted odds ratio (95% confidence interval). Factors used for multivariate analyses included age ≥65 year, gender, medical/
surgical conditions, hospital levels, comorbid conditions and infections other than skin/soft tissue (SST)Shen and Lu BMC Infectious Diseases 2010, 10:151
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subsequent systemic infection [27,28]. Although "infec-
tions due to vascular device/implant" are a common
cause of hospitalization in patients with cancer or ESRD,
most of them have local or non-critical infection and do
not require intensive care [28,29].
This study has several other limitations. First, the defi-
nitions of SSTIs in this study relied on the coding in stead
of the clinical, microbiological or pathological criteria,
the accuracy of the diagnosis and coding could not be
verified. Because only five diagnostic codes were avail-
able, some cases with SSTIs could have been missed. Sec-
ond, the quality of data could not be audited for the
purpose of research. Third, we could not differentiate the
timing for the occurrences of SSTIs, non-SST infections
and ICU admission. Therefore, whether these SST and
non-SST infections were community-acquired or health-
care-associated could not be ascertained. Fourth, hospital
mortality might be underestimated for unable to verify
through linkage of death certificate. Finally, detailed anal-
yses were only performed in the six most common SSTIs
because of small number in the others. Despite these, our
study is strengthened by the large number of patients
retrieved from a nationwide population-based dataset,
which can provide an unbiased selection and enhance the
generalization.
Conclusions
In conclusion, different proportional distributions of
SSTIs were present in ICU and non-ICU patients.
Although SSTIs varied greatly in many aspects, the pres-
ence of non-SST infections, which occurred in nearly
one-third of the patients, consistently increased the risks
of ICU admission and hospital mortality across most
common SSTIs.
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